Lancaster Capital is an early-stage equity investment fund based in Glasgow, Scotland, founded in 2012. The firm acts as a hub for like-minded private investors and focuses on seed-stage companies in the healthcare, biotechnology, and manufacturing industries within the United Kingdom. Notable investments include Taragenyx and Curapel.